Institution · Damien Foundation
Most cited papers from Damien Foundation
What are the most cited papers from Damien Foundation?
The most cited paper from Damien Foundation is "Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis" (Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim et al., 2010), with 660 citations. Next come "Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients" (324) and "Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard" (249).
Showing 50 of 61 papers. Every paper with more than 12 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim et al. · American Journal of Respiratory and Critical Care Medicine | 4 May 2010 | 660 |
| 2 | Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients K. J. M. Aung, Armand Van Deun, Erik De Clercq et al. · The International Journal of Tuberculosis and Lung Disease | 11 Sep 2014 | 324 |
| 3 | Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard Armand Van Deun, K. J. M. Aung, Valentin Bola et al. · Journal of Clinical Microbiology | 12 Jun 2013 | 249 |
| 4 | MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network Giovanni Battista Migliori et al. · International Journal of Infectious Diseases | 13 Feb 2020 | 236 |
| 5 | Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report Sergey E. Borisov et al. · European Respiratory Journal | 10 Oct 2019 | 181 |
| 6 | Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients Armand Van Deun, K. J. M. Aung, Md Anwar Hossain et al. · The International Journal of Tuberculosis and Lung Disease | 8 Jan 2015 | 99 |
| 7 | Genotypic and Phenotypic Heterogeneity amongMycobacterium tuberculosisIsolates from Pulmonary Tuberculosis Patients Isdore Chola Shamputa, Leen Rigouts, Lovet Achale Eyongeta et al. · Journal of Clinical Microbiology | Dec 2004 | 98 |
| 8 | SpecificgyrAgene mutations predict poor treatment outcome in MDR-TB Leen Rigouts, Nele Coeck, Mourad Gumusboga et al. · Journal of Antimicrobial Chemotherapy | 24 Nov 2015 | 96 |
| 9 | Gender differences in tuberculosis: a prevalence survey done in Bangladesh. Mohammed Sultan Salim, Eugene R Declercq, Armand Van Deun et al. · PubMed | Aug 2004 | 91 |
| 10 | Structural purity of magnetite nanoparticles in magnetotactic bacteria Anna Fischer, Manuel Schmitz, Barbara Aichmayer et al. · Journal of The Royal Society Interface | 19 Jan 2011 | 83 |
| 11 | Management of Discourse in Group Therapy for Aphasia Nina N. Simmons‐Mackie, Roberta J. Elman, Audrey L. Holland et al. · Topics in Language Disorders | 2007 | 81 |
| 12 | Turning liabilities into resources: informal village doctors and tuberculosis control in Bangladesh MA Hamid Salim · Bulletin of the World Health Organization | Jun 2006 | 64 |
| 13 | Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study Onno W. Akkerman et al. · International Journal of Infectious Diseases | 3 Apr 2019 | 57 |
| 14 | Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB. Abdul Hamid Salim, K. J. M. Aung, Md. Arif Hossain et al. · PubMed | Nov 2006 | 53 |
| 15 | Limitations and requirements for quality control of sputum smear microscopy for acid-fast bacilli. Armand Van Deun, Françoise Portaels · PubMed | Sep 1998 | 51 |
| 16 | Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort S Koirala et al. · Pulmonology | 20 Mar 2021 | 49 |
| 17 | Purified Bovine BMP Extract and Collagen for Spine Arthrodesis Christopher J. Damien, Dieter Grob, Scott D. Boden et al. · Spine | Aug 2002 | 47 |
| 18 | Clustering of leprosy beyond the household level in a highly endemic setting on the Comoros, an observational study Nimer Ortuno Gutierrez, Abdallah Baco, Sofie Marijke Braet et al. · BMC Infectious Diseases | 7 Jun 2019 | 46 |
| 19 | Socio Economic Position in TB Prevalence and Access to Services: Results from a Population Prevalence Survey and a Facility-Based Survey in Bangladesh Shahed Hossain, Mohammad Abdul Quaiyum, Khalequ Zaman et al. · PLoS ONE | 27 Sep 2012 | 46 |
| 20 | Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence Arnaud Trébucq, Tom Decroo, Armand Van Deun et al. · Journal of Clinical Medicine | 25 Dec 2019 | 45 |
| 21 | Ebola, fragile health systems and tuberculosis care: a call for pre-emptive action and operational research Rony Zachariah, Noel Ortuño, Veerle Hermans et al. · The International Journal of Tuberculosis and Lung Disease | 13 Oct 2015 | 42 |
| 22 | Forecasting the incidence of dengue in Bangladesh—Application of time series model Shabnam Naher, Fazle Rabbi, Md. Moyazzem Hossain et al. · Health Science Reports | 8 Jun 2022 | 41 |
| 23 | Anti-tuberculosis drug resistance in Bangladesh: reflections from the first nationwide survey S. M. Mostafa Kamal, Md Anowar Hossain, Salma Sultana et al. · The International Journal of Tuberculosis and Lung Disease | 9 Jan 2015 | 38 |
| 24 | Health-related quality of life among thalassemia patients in Bangladesh using the SF-36 questionnaire Md. Jubayer Hossain, Md Wahidul Islam, Ummi Rukaiya Munni et al. · Scientific Reports | 12 May 2023 | 34 |
| 25 | The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines José Antonio Caminero, Alberto L. García‐Basteiro, Adrián Rendón et al. · European Respiratory Journal | Oct 2019 | 32 |
| 26 | Intervention to increase detection of childhood tuberculosis in Bangladesh Khurshid Talukder, Md Abdul Hamid Salim, Iftia Jerin et al. · The International Journal of Tuberculosis and Lung Disease | 19 Dec 2011 | 32 |
| 27 | Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study Giovanni Battista Migliori et al. · Jornal Brasileiro de Pneumologia | 30 Apr 2022 | 31 |
| 28 | Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts Nimer Ortuno Gutierrez, Younoussa Assoumani, Andriamira Randrianantoandro et al. · BMC Infectious Diseases | Dec 2019 | 31 |
| 29 | Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB Armand Van Deun, Tom Decroo, Christopher Kuaban et al. · The International Journal of Tuberculosis and Lung Disease | Sep 2019 | 31 |
| 30 | On the Potential, Feasibility, and Effectiveness of Chat Bots in Public Health Research Going Forward Stan Mierzwa, Samir Souidi, Terry Conroy et al. · Online Journal of Public Health Informatics | 20 Sep 2019 | 31 |
| 31 | PERFORMANCE OF SMARTPHONE-BASED DIGITAL IMAGES FOR CERVICAL CANCER SCREENING IN A LOW-RESOURCE CONTEXT Phuong Lien Tran, Caroline Benski, Manuela Viviano et al. · International Journal of Technology Assessment in Health Care | 2018 | 31 |
| 32 | Does being female provide a neuroprotective advantage following spinal cord injury? DamienD Pearse, JeffreyP Datto, Yang Yang et al. · Neural Regeneration Research | 2015 | 29 |
| 33 | Detection of the Sgr A* activity at 3.8 and 4.8 $\mathsf{\mu}$m with NACO Y. Clénet, Daniel Rouan, Damien Gratadour et al. · Astronomy and Astrophysics | 23 Aug 2004 | 28 |
| 34 | Mycobacterium tuberculosisborderlinerpoBmutations: emerging from the unknown Armand Van Deun, Tom Decroo, K. J. M. Aung et al. · European Respiratory Journal | 29 Apr 2021 | 26 |
| 35 | Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens. Armand Van Deun, K. J. M. Aung, Subhadeep Chowdhury et al. · PubMed | Feb 1999 | 26 |
| 36 | Global Public Health Impact of Recovered Supplies from Operating Rooms: A Critical Analysis with National Implications Eric L. Wan, Li Hui Xie, Miceile D. Barrett et al. · World Journal of Surgery | 15 Oct 2014 | 26 |
| 37 | THE EVIDENCE FOR LATE-ONSET PRE-ECLAMPSIA AS A MATERNOGENIC DISEASE OF PREGNANCY Enrico Maria Ferrazzi, Tamara Stampalija, Jean Aupont · Fetal and Maternal Medicine Review | Feb 2013 | 25 |
| 38 | Exploring clustering of leprosy in the Comoros and Madagascar: A geospatial analysis Nimer Ortuno Gutierrez, Aboubacar Mzembaba, Stéphanie Ramboarina et al. · International Journal of Infectious Diseases | 12 May 2021 | 24 |
| 39 | Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts Younoussa Assoumani, Said Nourdine Samidine, Auke T. Bergeman et al. · BMC Infectious Diseases | 9 May 2023 | 23 |
| 40 | First-line tuberculosis treatment with double-dose rifampicin is well tolerated Aung Kya Jai Maug, Md. Arif Hossain, Mourad Gumusboga et al. · The International Journal of Tuberculosis and Lung Disease | May 2020 | 21 |
| 41 | Sputum smear microscopy in the Xpert® MTB/RIF era Armand Van Deun, Sabira Tahseen, Dissou Affolabi et al. · The International Journal of Tuberculosis and Lung Disease | 19 Dec 2018 | 20 |
| 42 | High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss Mahamadou Bassirou Souleymane, Alberto Piubello, Ibrahim Mamane Lawan et al. · European Respiratory Journal | 23 Jul 2020 | 19 |
| 43 | Les émotions à l’épreuve du genre Damien Boquet, Didier Lett · Clio | 2018 | 19 |
| 44 | International open trial of uniform multidrug therapy regimen for leprosy patients Manickam Ponnaiah, Sanjay Madhav Mehendale, Nagaraju Bathyala et al. · The Indian Journal of Medical Research | Oct 2016 | 19 |
| 45 | Endogenous reactivation and true treatment failure as causes of recurrent tuberculosis in a high incidence setting with a low HIV infection Isdore Chola Shamputa, Armand Van Deun, Md Abdul Hamid Salim et al. · Tropical Medicine & International Health | Jun 2007 | 19 |
| 46 | The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance Armand Van Deun, Tom Decroo, Aung Kya Jai Maug et al. · PLoS ONE | 18 May 2020 | 18 |
| 47 | New-Onset Psychosis in a Multi-Drug Resistant Tuberculosis Patient on Cycloserine in Calabar, Nigeria: A Case Report Otu AA, JB Offor, IA Ekpor et al. · Tropical Journal of Pharmaceutical Research | 25 Feb 2014 | 18 |
| 48 | Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis James A. Seddon et al. · The Lancet Infectious Diseases | 6 Jun 2025 | 16 |
| 49 | Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen Pauline Lempens, Tom Decroo, K. J. M. Aung et al. · International Journal of Infectious Diseases | 20 Aug 2020 | 15 |
| 50 | Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi François Ciza, Tinne Gils, Michel Sawadogo et al. · Journal of Clinical Medicine | 16 Jun 2020 | 15 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.